Estar Medical is committed to the innovation and development of medical devices used for autologous regenerative biologics and to the creation of autologous therapies for the purpose of improving the patient’s quality of life.
Estar Medical was founded in 1992 by Aaron Esteron – a polymer-science expert, entrepreneur and prolific inventor. Mr. Esteron, a pioneer in the design and development of vacuum collection and separation systems for blood and urine, was one of the first in the world to commercialize this innovative line of products being successfully and globally manufactured and distributed for many years both in the diagnostic and medical device fields.
Estar Medical is globally recognized as the leading provider of a patented platform method to produce Autologous Platelet Rich Plasma (PRP) and other related Cell Therapy technologies for human use. This cutting edge platform technology is distributed under the registered trademarks of Tropocells® and Cellenis®, processes the patient’s own blood for the purpose of using the platelets, cells and essential proteins for indications in various medical disciplines such as dermatology, aesthetics, orthopedics, sports medicine, wound care, pain management, dental, ophthalmology, veterinary and more. Estar Medical’s unique products can be applied either on a standalone basis or as a complementary along with other biologics and therapeutic methods. The Tropocells® and Cellenis® innovative product portfolio is based on a proprietary technology which is EU and US patented, FDA cleared (510K for orthopedic applications), CE certified (Class IIb), ISO 13485 approved and working under strict GMP regime.